Drug Information Related to Actoplus Met
01. MedImpact Study Demonstrates Health Risks for Diabetics May be Reduced...
SAN DIEGO -- MedImpact, the nation's largest pharmacy benefit
management (PBM) company that does not sell drugs, today announced
findings from a research study that found patients were 50 percent more
likely to be compliant using a single pill. The study compared...
02. Diabetes Patients withdrawn from Avandia Are Most Likely Switched to ....
NEW YORK -- New research from TNS Healthcare's
DiabetesDynamics USA[TM] shows that between July and September 2007 just
over half of all patients taken off Avandia because of reported links to
cardiac risk were switched to one of the new first-in-class
anti-diab...
03. ACTOplus met(TM) (pioglitazone HCl and metformin HCl) Approved by the ...
Takeda Pharmaceuticals North America, Inc.
(TPNA) today announced that the U.S. Food and Drug Administration (FDA) has
approved the New Drug Application (NDA) for ACTOplus met(TM) for the
treatment of type 2 diabetes. This is the second Takeda product approved
in the...
04. Takeda Submits New Drug Application for Extended-Release Type 2 ......
Takeda Global Research & Development
Center (TGR&D) today announced that the company has submitted a New Drug
Application (NDA) for an extended-release version of the combination
medication ACTOplus met™ (pioglitazone HCl and metformin HCl) to the United
...
05. Implementing intensified treatment strategies for patients with type 2...
(6.) US Food and Drug Administration. Information for Healthcare Professionals: Pioglitazone HCI (marketed as Actos, Actoplus Met, and Duet-act). http://www.fda.gov/cder/drug/infopage/ pioglitazone/default.htm. Accessed August 31, 2007.
...
06. GlaxoSmithKline | Drug Store News | Find Articles at BNET
The Food and Drug Administration announced that GlaxoSmithKline has agreed to add new information to the existing black-boxed warning on its Type 2 diabetes drug Avandia, warning of the drug's potential increased risk for heart attack.
...
07. New diabetes treatments could improve control, monitoring options ......
New treatments for people with diabetes potentially could hit pharmacy shelves soon, including two first-in-class pharmaceuticals with blockbuster potential to help treat the disease for type 2 diabetics and a pair of continuous glucose monitors to manage blood glucos...